Literature DB >> 12625868

Gene expression of CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and hPXR in three different human colon carcinoma cell lines.

Arabelle Pfrunder1, Heike Gutmann, Christoph Beglinger, Jürgen Drewe.   

Abstract

Colon carcinoma cell lines are used widely as screening models for intestinal absorption of drugs. However, the expression of important transport systems and of metabolic enzymes is not completely characterized yet. The expression and inducibility of multidrug resistance gene 1 (MDR1) and cytochrome P450 isoform 3A4 (CYP3A4) was investigated in Caco-2 parental, Caco-2 TC-7 (TC-7) and LS180 cell lines. In the same three cell lines, we investigated the expression of isoforms of the multidrug resistance associated protein family (MRP1-MRP5) and the human pregnane X receptor (hPXR), which may be important for MDR1 and CYP3A4 induction. Cells were treated with rifampicin or 1alpha,25-dihydroxycholecalciferol (1,25(OH)(2)D(3)) for 72 h and the total RNA was extracted. Afterwards reverse transcription real-time polymerase chain reaction (TaqMan) assay was performed to determine the mRNA expression level. We have shown that in LS180 cells, MDR1 and CYP3A4 were inducible with both inducers. In Caco-2 parental and TC-7 cells, CYP3A4 was only inducible with 1,25(OH)(2)D(3). Furthermore, differences were shown in gene expression of several transport proteins (MDR1 and MRP1-MRP5) and CYP3A4 in different human colon carcinoma derived cell lines. hPXR mRNA was expressed in all three cell lines but the amount of mRNA detected was significantly higher in LS180 cells than in Caco-2 and TC-7 cells. We concluded that LS180 cells were a suitable model to study MDR1 and CYP3A4 induction, but for drug transport studies Caco-2 parental and TC-7 cells would be preferred as the more physiological model.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12625868     DOI: 10.1111/j.2042-7158.2003.tb02434.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  27 in total

1.  Metabolic and efflux properties of Caco-2 cells stably transfected with nuclear receptors.

Authors:  Timo Korjamo; Jukka Mönkkönen; Jouko Uusitalo; Miia Turpeinen; Olavi Pelkonen; Paavo Honkakoski
Journal:  Pharm Res       Date:  2006-08-09       Impact factor: 4.200

2.  Binary and ternary combinations of anti-HIV protease inhibitors: effect on gene expression and functional activity of CYP3A4 and efflux transporters.

Authors:  Deep Kwatra; Aswani Dutt Vadlapudi; Ramya Krishna Vadlapatla; Varun Khurana; Dhananjay Pal; Ashim K Mitra
Journal:  Drug Metabol Drug Interact       Date:  2014

3.  Differential regulation of intestinal efflux transporters by pregnancy in mice.

Authors:  Jamie E Moscovitz; Gabriel Yarmush; Guadalupe Herrera-Garcia; Grace L Guo; Lauren M Aleksunes
Journal:  Xenobiotica       Date:  2017-01-03       Impact factor: 1.908

4.  Interaction of the mitotic kinesin Eg5 inhibitor monastrol with P-glycoprotein.

Authors:  Tanja Peters; Heike Lindenmaier; Walter E Haefeli; Johanna Weiss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-12-20       Impact factor: 3.000

5.  Effects of budesonide on P-glycoprotein expression in intestinal cell lines.

Authors:  A Maier; C Zimmermann; C Beglinger; J Drewe; H Gutmann
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

Review 6.  Multidrug resistance-associated proteins 3, 4, and 5.

Authors:  Piet Borst; Cornelia de Wolf; Koen van de Wetering
Journal:  Pflugers Arch       Date:  2006-04-04       Impact factor: 3.657

7.  Fine-tuning translation kinetics selection as the driving force of codon usage bias in the hepatitis A virus capsid.

Authors:  Lluís Aragonès; Susana Guix; Enric Ribes; Albert Bosch; Rosa M Pintó
Journal:  PLoS Pathog       Date:  2010-03-05       Impact factor: 6.823

Review 8.  The pregnane X receptor: from bench to bedside.

Authors:  Xiaochao Ma; Jeffrey R Idle; Frank J Gonzalez
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-07       Impact factor: 4.481

9.  Comparison of the induction profile for drug disposition proteins by typical nuclear receptor activators in human hepatic and intestinal cells.

Authors:  P Martin; R Riley; D J Back; A Owen
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

10.  PXR-mediated induction of P-glycoprotein by anticancer drugs in a human colon adenocarcinoma-derived cell line.

Authors:  Stefan Harmsen; I Meijerman; C L Febus; R F Maas-Bakker; J H Beijnen; J H M Schellens
Journal:  Cancer Chemother Pharmacol       Date:  2009-12-30       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.